Curcumin, a natural compound from rhizomes of curcuma longa inhibits cell growth of liver carcinoma cells / Nur Shazwani Mokhtar

Hepatocellular carcinoma is the most common liver cancer form in adults. Curcumin, a non-volatile, yellow colouring agent, contained in turmeric (Curcuma longa L.) was claimed to have anticancer activities on most cancers, including liver cancer.The aim of this study is to evaluate the anticancer ac...

Full description

Saved in:
Bibliographic Details
Main Author: Mokhtar, Nur Shazwani
Format: Thesis
Language:English
Published: 2009
Subjects:
Online Access:https://ir.uitm.edu.my/id/eprint/107211/1/107211.PDF
Tags: Add Tag
No Tags, Be the first to tag this record!
id my-uitm-ir.107211
record_format uketd_dc
spelling my-uitm-ir.1072112024-12-10T23:12:36Z Curcumin, a natural compound from rhizomes of curcuma longa inhibits cell growth of liver carcinoma cells / Nur Shazwani Mokhtar 2009 Mokhtar, Nur Shazwani Pharmaceutical industry Pharmaceutical chemistry Hepatocellular carcinoma is the most common liver cancer form in adults. Curcumin, a non-volatile, yellow colouring agent, contained in turmeric (Curcuma longa L.) was claimed to have anticancer activities on most cancers, including liver cancer.The aim of this study is to evaluate the anticancer activities of curcumin from rhizomes of Curcuma longa L. on human liver cancer cells. In this study, two types of cell lines, HepG2 (human hepatocarcinoma) cells and WRL 68 (non-tumourigenic fetal liver) cells were used. Cells were plated in 96-wellplates and incubated in conditions of 95% 02, 5% C02, at 3 7°C. Five concentrations of curcumin extracts; 0.1, 1, 10, 100, and 1000 µg/ml were used and MTS assay was used to measure cell viability. Concentration response curve for ethyl acetate extract of curcumin and methanol extract of curcumin were constructed to determine the effects of concentration on cell viability and to calculate the median inhibitory concentrations (IC50) for each extract. IC50 for curcumin (MeOH) in HepG2 cells and curcumin (EA) in HepG2 cells were 125.3 ± 41.lµg/ml and 146.5± 52.0µg/ml respectively. While, IC50 for curcumin (MeOH) in WRL 68 cells and curcumin (EA) in WRL 68 cells were 224.3 ± 57.2 µg/ml and 263 ± 55.7 µg/ml respectively. The result showed that methanol extract of curcumin was having greater anticancer activity on HepG2 cells. This study can contribute to the development of more effective, safer and cheaper natural based cancer drugs. 2009 Thesis https://ir.uitm.edu.my/id/eprint/107211/ https://ir.uitm.edu.my/id/eprint/107211/1/107211.PDF text en public degree Universiti Teknologi MARA (Kampus Puncak Alam) Faculty of Pharmacy Jannah, Noor
institution Universiti Teknologi MARA
collection UiTM Institutional Repository
language English
advisor Jannah, Noor
topic Pharmaceutical industry
Pharmaceutical chemistry
spellingShingle Pharmaceutical industry
Pharmaceutical chemistry
Mokhtar, Nur Shazwani
Curcumin, a natural compound from rhizomes of curcuma longa inhibits cell growth of liver carcinoma cells / Nur Shazwani Mokhtar
description Hepatocellular carcinoma is the most common liver cancer form in adults. Curcumin, a non-volatile, yellow colouring agent, contained in turmeric (Curcuma longa L.) was claimed to have anticancer activities on most cancers, including liver cancer.The aim of this study is to evaluate the anticancer activities of curcumin from rhizomes of Curcuma longa L. on human liver cancer cells. In this study, two types of cell lines, HepG2 (human hepatocarcinoma) cells and WRL 68 (non-tumourigenic fetal liver) cells were used. Cells were plated in 96-wellplates and incubated in conditions of 95% 02, 5% C02, at 3 7°C. Five concentrations of curcumin extracts; 0.1, 1, 10, 100, and 1000 µg/ml were used and MTS assay was used to measure cell viability. Concentration response curve for ethyl acetate extract of curcumin and methanol extract of curcumin were constructed to determine the effects of concentration on cell viability and to calculate the median inhibitory concentrations (IC50) for each extract. IC50 for curcumin (MeOH) in HepG2 cells and curcumin (EA) in HepG2 cells were 125.3 ± 41.lµg/ml and 146.5± 52.0µg/ml respectively. While, IC50 for curcumin (MeOH) in WRL 68 cells and curcumin (EA) in WRL 68 cells were 224.3 ± 57.2 µg/ml and 263 ± 55.7 µg/ml respectively. The result showed that methanol extract of curcumin was having greater anticancer activity on HepG2 cells. This study can contribute to the development of more effective, safer and cheaper natural based cancer drugs.
format Thesis
qualification_level Bachelor degree
author Mokhtar, Nur Shazwani
author_facet Mokhtar, Nur Shazwani
author_sort Mokhtar, Nur Shazwani
title Curcumin, a natural compound from rhizomes of curcuma longa inhibits cell growth of liver carcinoma cells / Nur Shazwani Mokhtar
title_short Curcumin, a natural compound from rhizomes of curcuma longa inhibits cell growth of liver carcinoma cells / Nur Shazwani Mokhtar
title_full Curcumin, a natural compound from rhizomes of curcuma longa inhibits cell growth of liver carcinoma cells / Nur Shazwani Mokhtar
title_fullStr Curcumin, a natural compound from rhizomes of curcuma longa inhibits cell growth of liver carcinoma cells / Nur Shazwani Mokhtar
title_full_unstemmed Curcumin, a natural compound from rhizomes of curcuma longa inhibits cell growth of liver carcinoma cells / Nur Shazwani Mokhtar
title_sort curcumin, a natural compound from rhizomes of curcuma longa inhibits cell growth of liver carcinoma cells / nur shazwani mokhtar
granting_institution Universiti Teknologi MARA (Kampus Puncak Alam)
granting_department Faculty of Pharmacy
publishDate 2009
url https://ir.uitm.edu.my/id/eprint/107211/1/107211.PDF
_version_ 1818588215274110976